Skip to main content
Immunology logoLink to Immunology
. 1981 Feb;42(2):307–311.

The guinea-pig complement-activating lymphocyte surface component (GPCA): a mouse T-cell marker distinct from Thy-1.

F Kierszenbaum, D B Budzko
PMCID: PMC1458086  PMID: 6970179

Abstract

Mouse lymphocytes selectively expressing sensitivity to antibody-independent complement-mediated lysis by normal guinea-pig serum have been previously shown to be identical with T cells. This correlation has raised the question addressed in this work of whether or not the complement-activating surface component and Thy-1 were the same marker. S.49 mouse lymphoblastoid cells, sensitive to killing by anti-Thy-1.2 antibodies plus a source of complement activity devoid of non-specific cytotoxicity, were not sensitive to the non-specific, antibody-independent lytic effects of normal guinea-pig serum. Furthermore, rat thymus cell suspensions containing 93%--95% Thy-1-bearing cells were only partially susceptible (20%--35%) to guinea-pig serum cytotoxicity. Young rat thymus cells virtually devoid of guinea-pig serum-sensitive cells (less than 2%) were readily lysed by antirat Thy-1 and complement (greater than 98%). While these results do not exclude the possibility that Thy-1 may constitute an indirect requirement for T cells to manifest sensitivity to GPS cytotoxicity, it is clear that this antigen does not confer such sensitivity by itself. Therefore, GPCA--the guinea-pig complement-activating marker of murine T cells--is not identical with Thy-1 and represents a distinct surface component of T lymphocytes which manifests itself in terms of a non-specific, but selective ability to activate complement.

Full text

PDF
307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barclay A. N., Letarte-Muirhead M., Williams A. F. Purification of the Thy-1 molecule from rat brain. Biochem J. 1975 Dec;151(3):699–706. doi: 10.1042/bj1510699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Budzko D. B., Kierszenbaum F. Cytotoxic effects of normal sera on lymphoid cells. II. Requirements for inhibition of nonspecific serum cytotoxicity by agarose. Transplantation. 1977 Apr;23(4):337–342. doi: 10.1097/00007890-197704000-00007. [DOI] [PubMed] [Google Scholar]
  3. Budzko D. B., Kierszenbaum F., Waksman B. H. Cytotoxic effects of normal sera on lymphoid cells. III. Selective killing of mouse T cells by normal guinea pig serum. J Immunol. 1977 Aug;119(2):381–386. [PubMed] [Google Scholar]
  4. Douglas T. C. Occurrence of a theta-like antigen in rats. J Exp Med. 1972 Nov 1;136(5):1054–1062. doi: 10.1084/jem.136.5.1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kierszenbaum F., Budzko D. B. Changes occurring on the surface of mouse T cells during concanavalin A-induced lymphoblastic transformation. Immunology. 1979 Dec;38(4):827–834. [PMC free article] [PubMed] [Google Scholar]
  6. Kierszenbaum F., Budzko D. B. Cytotoxic effects of normal sera on lymphoid cells. I. Antibody-independent killing of heterologous thymocytes by guinea pig, rabbit, and human sera: role of the alternative pathway of complement activation. Cell Immunol. 1977 Mar 1;29(1):137–146. doi: 10.1016/0008-8749(77)90282-9. [DOI] [PubMed] [Google Scholar]
  7. Kierszenbaum F., Budzko D. B. Identification and characterization of a new subset of rat T lymphocytes. J Immunol. 1978 Jul;121(1):166–171. [PubMed] [Google Scholar]
  8. Kierszenbaum F., Budzko D. B., Miller H. C. Selective removal of T cell function from mouse lymphocyte suspensions by treatment with normal guinea pig serum. J Immunol. 1980 Apr;124(4):1599–1602. [PubMed] [Google Scholar]
  9. Micheel B., Pasternak G., Steuden J. Demonstration of theta-AKR differentiation antigen in rat tissue by mouse alloantiserum. Nat New Biol. 1973 Feb 14;241(111):221–222. doi: 10.1038/newbio241221a0. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES